Skip to content
healthcare.dev

Deferasirox Oral Granules

NDC 42806-373, deferasirox, granule, from EPIC PHARMA, LLC.

Product NDC
42806-373
Status
Listed
Labeler
EPIC PHARMA, LLC
Dosage form
GRANULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214559
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42806-373 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX360 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
42806-373-304280603733030 PACKET in 1 CARTON (42806-373-30) / 1 GRANULE in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7eda83c3-a282-47f6-9f06-d2f9612f5c5b

Use it

Look up 42806-373 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42806-373 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42806-373. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.